Mübeccel Akdis to Humans
This is a "connection" page, showing publications Mübeccel Akdis has written about Humans.
Connection Strength
0.095
-
B-cell responses in allergen immunotherapy. Curr Opin Allergy Clin Immunol. 2019 12; 19(6):632-639.
Score: 0.007
-
The use of biologics for immune modulation in allergic disease. J Clin Invest. 2019 03 18; 129(4):1452-1462.
Score: 0.007
-
Comparison of regulatory B cells in asthma and allergic rhinitis. Allergy. 2019 04; 74(4):815-818.
Score: 0.006
-
Mechanisms of allergen-specific immunotherapy: Diverse mechanisms of immune tolerance to allergens. Ann Allergy Asthma Immunol. 2018 09; 121(3):306-312.
Score: 0.006
-
Modified Allergens for Immunotherapy. Curr Allergy Asthma Rep. 2018 02 16; 18(2):9.
Score: 0.006
-
Novel mechanisms in immune tolerance to allergens during natural allergen exposure and allergen-specific immunotherapy. Curr Opin Immunol. 2017 Oct; 48:74-81.
Score: 0.006
-
T-cell tolerance to inhaled allergens: mechanisms and therapeutic approaches. Expert Opin Biol Ther. 2008 Jun; 8(6):769-77.
Score: 0.003
-
Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives. Allergy. 2021 06; 76(6):1640-1660.
Score: 0.002
-
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position Paper. Allergy. 2021 06; 76(6):1624-1628.
Score: 0.002
-
Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021 02; 76(2):428-455.
Score: 0.002
-
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement. Allergy. 2020 11; 75(11):2764-2774.
Score: 0.002
-
Advances and recent developments in asthma in 2020. Allergy. 2020 12; 75(12):3124-3146.
Score: 0.002
-
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy. 2020 10; 75(10):2445-2476.
Score: 0.002
-
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020). Allergy. 2021 03; 76(3):689-697.
Score: 0.002
-
Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status. Allergy. 2021 02; 76(2):510-532.
Score: 0.002
-
Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy. 2021 02; 76(2):533-550.
Score: 0.002
-
A compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy. 2020 10; 75(10):2503-2541.
Score: 0.002
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. Allergy. 2020 07; 75(7):1546-1554.
Score: 0.002
-
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020 07; 75(7):1564-1581.
Score: 0.002
-
Human type 2 innate lymphoid cells disrupt skin keratinocyte tight junction barrier by IL-13. Allergy. 2019 12; 74(12):2534-2537.
Score: 0.002
-
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid. J Allergy Clin Immunol. 2019 06; 143(6):2190-2201.e9.
Score: 0.002
-
Rhinovirus Species-Specific Antibodies Differentially Reflect Clinical Outcomes in Health and Asthma. Am J Respir Crit Care Med. 2018 12 15; 198(12):1490-1499.
Score: 0.002
-
Laundry detergents and detergent residue after rinsing directly disrupt tight junction barrier integrity in human bronchial epithelial cells. J Allergy Clin Immunol. 2019 05; 143(5):1892-1903.
Score: 0.002
-
Intralymphatic Immunotherapy: Update and Unmet Needs. Int Arch Allergy Immunol. 2019; 178(2):141-149.
Score: 0.002
-
Chronic rhinosinusitis: pathogenesis, therapy options, and more. Expert Opin Pharmacother. 2018 11; 19(16):1805-1815.
Score: 0.002
-
Precision/Personalized Medicine in Allergic Diseases and Asthma. Arch Immunol Ther Exp (Warsz). 2018 Dec; 66(6):431-442.
Score: 0.002
-
Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinoviruses. J Allergy Clin Immunol. 2019 04; 143(4):1403-1415.
Score: 0.002
-
The concepts of asthma endotypes and phenotypes to guide current and novel treatment strategies. Expert Rev Respir Med. 2018 09; 12(9):733-743.
Score: 0.002
-
Staphylococcus aureus enhances the tight junction barrier integrity in healthy nasal tissue, but not in nasal polyps. J Allergy Clin Immunol. 2018 08; 142(2):665-668.e8.
Score: 0.002
-
A Fluorescent Probe to Unravel Functional Features of Cannabinoid Receptor CB1 in Human Blood and Tonsil Immune System Cells. Bioconjug Chem. 2018 02 21; 29(2):382-389.
Score: 0.002
-
Guidelines for the use of flow cytometry and cell sorting in immunological studies. Eur J Immunol. 2017 10; 47(10):1584-1797.
Score: 0.001
-
Human CD40 ligand-expressing type 3 innate lymphoid cells induce IL-10-producing immature transitional regulatory B cells. J Allergy Clin Immunol. 2018 07; 142(1):178-194.e11.
Score: 0.001
-
Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance. J Allergy Clin Immunol. 2017 Nov; 140(5):1250-1267.
Score: 0.001
-
Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells. Immunol Rev. 2017 07; 278(1):219-236.
Score: 0.001
-
Exposure to nonmicrobial N-glycolylneuraminic acid protects farmers' children against airway inflammation and colitis. J Allergy Clin Immunol. 2018 01; 141(1):382-390.e7.
Score: 0.001
-
Computational analysis of multimorbidity between asthma, eczema and rhinitis. PLoS One. 2017; 12(6):e0179125.
Score: 0.001
-
Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients. J Allergy Clin Immunol. 2018 01; 141(1):300-310.e11.
Score: 0.001
-
The relationship of serum vitamins A, D, E and LL-37 levels with allergic status, tonsillar virus detection and immune response. PLoS One. 2017; 12(2):e0172350.
Score: 0.001
-
Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes. J Allergy Clin Immunol. 2017 02; 139(2):388-399.
Score: 0.001
-
International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. J Allergy Clin Immunol. 2016 Feb; 137(2):358-68.
Score: 0.001
-
Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J Exp Med. 2009 Nov 23; 206(12):2701-15.
Score: 0.001